Matex International Past Earnings Performance
Past criteria checks 0/6
Matex International has been growing earnings at an average annual rate of 34%, while the Chemicals industry saw earnings declining at 20.4% annually. Revenues have been declining at an average rate of 31.6% per year.
Key information
34.0%
Earnings growth rate
37.3%
EPS growth rate
| Chemicals Industry Growth | 0.9% |
| Revenue growth rate | -31.6% |
| Return on equity | -35.1% |
| Net Margin | -41.5% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Matex International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 8 | -3 | 6 | 0 |
| 31 Mar 24 | 7 | -3 | 6 | 0 |
| 31 Dec 23 | 7 | -3 | 6 | 0 |
| 30 Sep 23 | 9 | 2 | 7 | 0 |
| 30 Jun 23 | 10 | 8 | 9 | 0 |
| 31 Mar 23 | 12 | 8 | 10 | 0 |
| 31 Dec 22 | 15 | 7 | 11 | 0 |
| 30 Sep 22 | 17 | 1 | 10 | 0 |
| 30 Jun 22 | 19 | -5 | 9 | 0 |
| 31 Mar 22 | 20 | -5 | 9 | 0 |
| 31 Dec 21 | 21 | -5 | 9 | 0 |
| 30 Sep 21 | 21 | -6 | 10 | 0 |
| 30 Jun 21 | 22 | -7 | 10 | 0 |
| 31 Mar 21 | 23 | -7 | 10 | 0 |
| 31 Dec 20 | 25 | -6 | 10 | 0 |
| 30 Sep 20 | 28 | -6 | 11 | 0 |
| 30 Jun 20 | 32 | -5 | 11 | 0 |
| 31 Mar 20 | 35 | -6 | 12 | 0 |
| 31 Dec 19 | 38 | -6 | 12 | 0 |
| 30 Sep 19 | 38 | -5 | 12 | 0 |
| 30 Jun 19 | 38 | -4 | 12 | 0 |
| 31 Mar 19 | 41 | -4 | 11 | 0 |
| 31 Dec 18 | 43 | -4 | 11 | 0 |
| 30 Sep 18 | 46 | -6 | 12 | 0 |
| 30 Jun 18 | 49 | -9 | 12 | 0 |
| 31 Mar 18 | 50 | -9 | 13 | 0 |
| 31 Dec 17 | 51 | -10 | 13 | 0 |
| 30 Sep 17 | 56 | -7 | 13 | 0 |
| 30 Jun 17 | 62 | -4 | 13 | 0 |
| 31 Mar 17 | 70 | -3 | 13 | 0 |
| 31 Dec 16 | 78 | -1 | 13 | 0 |
| 30 Sep 16 | 84 | -1 | 13 | 0 |
| 30 Jun 16 | 89 | 0 | 13 | 0 |
| 31 Mar 16 | 91 | -1 | 13 | 0 |
| 31 Dec 15 | 92 | -2 | 13 | 0 |
| 30 Sep 15 | 90 | -2 | 13 | 0 |
| 30 Jun 15 | 88 | -3 | 13 | 0 |
| 31 Mar 15 | 97 | 0 | 14 | 0 |
| 31 Dec 14 | 105 | 3 | 15 | 0 |
| 30 Sep 14 | 105 | 4 | 15 | 0 |
| 30 Jun 14 | 106 | 5 | 15 | 0 |
| 31 Mar 14 | 88 | 2 | 13 | 0 |
| 31 Dec 13 | 70 | 0 | 11 | 0 |
Quality Earnings: M15 is currently unprofitable.
Growing Profit Margin: M15 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M15 is unprofitable, but has reduced losses over the past 5 years at a rate of 34% per year.
Accelerating Growth: Unable to compare M15's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: M15 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (38.2%).
Return on Equity
High ROE: M15 has a negative Return on Equity (-35.14%), as it is currently unprofitable.